AB
PMVP icon

Amalgamated Bank’s PMV Pharmaceuticals PMVP Stock Holding History

Amalgamated Bank’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,279
Closed -$2K – 3090
2024
Q1 		$2K Sell
1,279
-2,152
-63% -$4.02K ﹤0.01% 2900
2023
Q4 		$11K Sell
3,431
-380
-10% -$1.01K ﹤0.01% 2846
2023
Q3 		$23K Hold
3,811
– – ﹤0.01% 2591
2023
Q2 		$24K Hold
3,811
– – ﹤0.01% 2658
2023
Q1 		$18K Sell
3,811
-854
-18% -$6.01K ﹤0.01% 2682
2022
Q4 		$41K Hold
4,665
– – ﹤0.01% 2512
2022
Q3 		$56K Hold
4,665
– – ﹤0.01% 2410
2022
Q2 		$66K Buy
4,665
+394
+9% +$5.73K ﹤0.01% 2346
2022
Q1 		$89K Buy
+4,271
New +$75.3K ﹤0.01% 2240

Other funds holding PMVP

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Amalgamated Bank's PMVP Position: Q2 2024 in Review

Amalgamated Bank sold out of PMV Pharmaceuticals (PMVP) in Q2 2024, closing a stake of 1,279 shares — an estimated $2K sold.

Amalgamated Bank first reported a position in PMVP in Q1 2022 and held it in 9 quarters. The position peaked at $89K in Q1 2022. 93 funds tracked by Wall St. Rank hold PMVP as of Q2 2024.

  • Amalgamated Bank reported no remaining PMV Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Amalgamated Bank sold 1,279 PMV Pharmaceuticals shares in Q2 2024, an estimated $2K.
  • Amalgamated Bank first reported a position in PMV Pharmaceuticals in Q1 2022 and held it in 9 quarters.
  • Amalgamated Bank's PMV Pharmaceuticals position peaked at $89K in Q1 2022.
  • 93 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q2 2024.

Based on Amalgamated Bank's 13F filing for Q2 2024, filed 12 Aug 2024.